Table 1 Baseline characteristic in 361 elderly patients with rectal cancer.

From: Comprehensive analysis of the prognostic value of pre-treatment nutritional indicators in elderly rectal cancer patients

Characteristic

No. of patients

Age (years)

 

   < 71

257 (71.2%)

   ≥ 71

104 (28.8%

Sex

 

  Male

222 (61.5%)

  Female

139 (38.5%)

TNM stage

 

  I

85 (23.5%)

  II

158 (43.8%)

  III

118 (32.7%)

T stage

 

  T1/2

106 (29.4%)

  T3/4

255 (70.6%)

N stage

 

  N0

243 (67.3%)

  N1/2

118 (32.7%)

Tumor size (cm)

 

   < 3.5

100 (27.7%)

   ≥ 3.5

261 (72.3%)

BMI

 

   < 26.49

249 (69.0%)

   ≥ 26.49

112 (31.0%)

PNI

 

   < 52.5

260 (72.0%)

   ≥ 52.5

101 (28.0%)

PAR

 

   < 6.38

207 (53.3%)

   ≥ 6.38

154 (42.7%)

GNRI

 

   < 108.58

263 (72.9%)

   ≥ 108.58

98 (27.1%)

ALI

 

   < 229.07

39 (10.8%)

   ≥ 229.07

322 (89.1%)

CEA

 

  No

219 (60.7%)

  Yes

142 (39.3%)

MRF

 

  No

272 (75.5%)

  Yes

89 (24.7%)

EMVI

 

  No

307 (85.5%)

  Yes

54 (15.0%)

Perineural invasion

 

  No

284 (78.7%)

  Yes

77 (21.3%)

Tumor deposit

 

  No

321 (88.9%)

  Yes

40 (11.1%)

  1. BMI body mass index; PNI prognostic nutritional index; PAR platelet-albumin ratio; GNRI the geriatric nutrition risk index, ALI the advanced lung cancer inflammation index; CEA carcinoembryonic antigen; MRF mesorectal fascia invasion; EMVI extramural vascular invasion.
Back to article page